161 related articles for article (PubMed ID: 25889187)
1. In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis.
Xiao X; Sun J; Chen Y; Huang RJ; Huang T; Qiao GG; Zhou YF; Liu YH
BMC Vet Res; 2015 Feb; 11():33. PubMed ID: 25889187
[TBL] [Abstract][Full Text] [Related]
2. In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.
Sun J; Xiao X; Huang RJ; Yang T; Chen Y; Fang X; Huang T; Zhou YF; Liu YH
BMC Vet Res; 2015 Dec; 11():293. PubMed ID: 26626889
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.
Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP
BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735
[TBL] [Abstract][Full Text] [Related]
4. Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China.
Mi K; Sun D; Li M; Hao H; Zhou K; Liu Z; Yuan Z; Huang L
Pathogens; 2021 Jan; 10(2):. PubMed ID: 33498972
[No Abstract] [Full Text] [Related]
5. Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.
Zhang L; Li Y; Wang Y; Sajid A; Ahmed S; Li X
J Vet Pharmacol Ther; 2018 Oct; 41(5):706-718. PubMed ID: 29696661
[TBL] [Abstract][Full Text] [Related]
6. PK/PD modelling of enrofloxacin against Glaesserella parasuis infection in pigs.
Yang B; Li XD; Chen X; Hong J; Liu C; Zheng JP; Ou ZY; Yu DJ
J Vet Pharmacol Ther; 2022 May; 45(3):291-300. PubMed ID: 35348230
[TBL] [Abstract][Full Text] [Related]
7. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
[TBL] [Abstract][Full Text] [Related]
8. PK/PD modeling of Ceftiofur Sodium against Haemophilus parasuis infection in pigs.
Li XD; Chi SQ; Wu LY; Liu C; Sun T; Hong J; Chen X; Chen XG; Wang GS; Yu DJ
BMC Vet Res; 2019 Aug; 15(1):272. PubMed ID: 31370843
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model.
Zhao Y; Guo LL; Fang B; Liu B
PLoS One; 2018; 13(12):e0209177. PubMed ID: 30596709
[TBL] [Abstract][Full Text] [Related]
10. The Epidemiologic and Pharmacodynamic Cutoff Values of Tilmicosin against Haemophilus parasuis.
Zhang P; Hao H; Li J; Ahmad I; Cheng G; Chen D; Tao Y; Huang L; Wang Y; Dai M; Liu Z; Yuan Z
Front Microbiol; 2016; 7():385. PubMed ID: 27047487
[TBL] [Abstract][Full Text] [Related]
11. Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against
Zhou YF; Sun Z; Wang RL; Li JG; Niu CY; Li XA; Feng YY; Sun J; Liu YH; Liao XP
Front Vet Sci; 2022; 9():811967. PubMed ID: 35187143
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Haemophilus parasuis by berberine and proteomic studies of its mechanism of action.
Jia Y; Hao C; Yang Q; Zhang W; Li G; Liu S; Hua X
Res Vet Sci; 2021 Sep; 138():62-68. PubMed ID: 34111715
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Streptococcus suis Serotype 2 at Varied Initial Inoculum Sizes.
Guo C; Liao X; Wang M; Wang F; Yan C; Xiao X; Sun J; Liu Y
Antimicrob Agents Chemother; 2016 Feb; 60(2):1114-20. PubMed ID: 26666923
[TBL] [Abstract][Full Text] [Related]
14. PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli.
Xiao X; Chen X; Yan K; Jiang L; Li R; Liu Y; Wang M; Wang Z
J Vet Pharmacol Ther; 2022 Jan; 45(1):83-91. PubMed ID: 34469000
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations.
Vilalta C; Giboin H; Schneider M; El Garch F; Fraile L
J Vet Pharmacol Ther; 2014 Dec; 37(6):542-9. PubMed ID: 24903473
[TBL] [Abstract][Full Text] [Related]
16. Effect of marbofloxacin on Haemophilus parasuis nasal carriage.
Vilalta C; Galofré N; Aragon V; Pérez de Rozas AM; Fraile L
Vet Microbiol; 2012 Sep; 159(1-2):123-9. PubMed ID: 22487455
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.
Zhang L; Wu X; Huang Z; Zhang N; Wu Y; Cai Q; Shen X; Ding H
Vet Microbiol; 2018 Jun; 219():100-106. PubMed ID: 29778180
[TBL] [Abstract][Full Text] [Related]
18. Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.
Gu M; Zhang N; Zhang L; Xiong M; Yang Y; Gu X; Shen X; Ding H
BMC Vet Res; 2015 Jul; 11():169. PubMed ID: 26209108
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial effect of Blumea balsamifera DC. essential oil against Haemophilus parasuis.
He C; Yang P; Wang L; Jiang X; Zhang W; Liang X; Yin L; Yin Z; Geng Y; Zhong Z; Song X; Zou Y; Li L; Lv C
Arch Microbiol; 2020 Nov; 202(9):2499-2508. PubMed ID: 32638056
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial pathway of cefquinome against Staphylococcus aureus based on label-free quantitative proteomics analysis.
Gao L; Zhu H; Chen Y; Yang Y
J Microbiol; 2021 Dec; 59(12):1112-1124. PubMed ID: 34751907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
